BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 16903923)

  • 21. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naïve and antigenic-specific cord blood Treg cells.
    Chang CC; Satwani P; Oberfield N; Vlad G; Simpson LL; Cairo MS
    Exp Hematol; 2005 Dec; 33(12):1508-20. PubMed ID: 16338494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells.
    Wu K; Bi Y; Sun K; Xia J; Wang Y; Wang C
    Scand J Immunol; 2008 Feb; 67(2):140-51. PubMed ID: 18201369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of inducible CD4+CD25+Foxp3+ regulatory T lymphocytes by porcine reproductive and respiratory syndrome virus (PRRSV).
    Wongyanin P; Buranapraditkun S; Chokeshai-Usaha K; Thanawonguwech R; Suradhat S
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):170-82. PubMed ID: 19709757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.
    Coenen JJ; Koenen HJ; Emmer PM; van Rijssen E; Hilbrands LB; Joosten I
    Transpl Immunol; 2007 Jun; 17(4):237-42. PubMed ID: 17493525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
    Liu Y; Amarnath S; Chen W
    Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of dendritic cells with regulatory properties.
    Ureta G; Osorio F; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2007 Apr; 39(3):633-7. PubMed ID: 17445563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
    Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
    Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S; Ghasemi M
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
    Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
    Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.
    Larmonier N; Marron M; Zeng Y; Cantrell J; Romanoski A; Sepassi M; Thompson S; Chen X; Andreansky S; Katsanis E
    Cancer Immunol Immunother; 2007 Jan; 56(1):48-59. PubMed ID: 16612596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.